{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:13:45Z","timestamp":1791328425809,"version":"4.3.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100022690","name":"Breakthrough T1D","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022690","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jlr.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jlr.2026.100975","type":"journal-article","created":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T23:40:15Z","timestamp":1767397215000},"page":"100975","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Chronic kidney disease induces distinct alterations of macrophage lipid metabolism in a mouse model of atherosclerosis"],"prefix":"10.1016","volume":"67","author":[{"given":"Keith","family":"Saum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3134-5341","authenticated-orcid":false,"given":"Xinyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thekkelnaycke","family":"Rajendiran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixia","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3486-9532","authenticated-orcid":false,"given":"Pradeep","family":"Kayampilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaeman","family":"Byun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3051-3141","authenticated-orcid":false,"given":"Farsad","family":"Afshinnia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subramaniam","family":"Pennathur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jlr.2026.100975_bib1","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/s41581-021-00423-5","article-title":"Lipoproteins and fatty acids in chronic kidney disease: molecular and metabolic alterations","volume":"17","author":"Noels","year":"2021","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.jlr.2026.100975_bib2","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1021\/acs.jproteome.6b00956","article-title":"Combined clinical phenotype and lipidomic analysis reveals the impact of chronic kidney disease on lipid metabolism","volume":"16","author":"Chen","year":"2017","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.jlr.2026.100975_bib3","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1681\/ASN.2017030350","article-title":"Impaired B-oxidation and altered complex lipid fatty acid partitioning with advancing CKD","volume":"29","author":"Afshinnia","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jlr.2026.100975_bib4","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1053\/j.ajkd.2018.11.010","article-title":"Lipids, apolipoproteins, and risk of atherosclerotic cardiovascular disease in persons with CKD","volume":"73","author":"Bajaj","year":"2019","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.jlr.2026.100975_bib5","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1172\/JCI59643","article-title":"Macrophage plasticity and polarization: in vivo veritas","volume":"122","author":"Sica","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jlr.2026.100975_bib6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrneph.2010.157","article-title":"Atherosclerosis in chronic kidney disease: the role of macrophages","volume":"7","author":"Kon","year":"2011","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.jlr.2026.100975_bib7","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41590-018-0113-3","article-title":"Regulation of macrophage immunometabolism in atherosclerosis","volume":"19","author":"Koelwyn","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jlr.2026.100975_bib8","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1161\/ATVBAHA.109.188995","article-title":"Renal dysfunction potentiates foam cell formation by repressing ABCA1","volume":"29","author":"Zuo","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jlr.2026.100975_bib9","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/j.1525-1594.2005.29097.x","article-title":"Expression of scavenger receptor CD36 in chronic renal failure patients","volume":"29","author":"Chmielewski","year":"2005","journal-title":"Artif. Organs"},{"key":"10.1016\/j.jlr.2026.100975_bib10","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3390\/metabo11050275","article-title":"Mass spectrometry-based lipidomics reveals differential changes in the accumulated lipid classes in chronic kidney disease","volume":"11","author":"Marczak","year":"2021","journal-title":"Metabolites"},{"key":"10.1016\/j.jlr.2026.100975_bib11","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1194\/jlr.M055624","article-title":"Top-down lipidomics of low density lipoprotein reveal altered lipid profi les in advanced chronic kidney disease","volume":"56","author":"Reis","year":"2015","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jlr.2026.100975_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/jci.insight.130317","article-title":"Increased lipogenesis and impaired B-oxidation predict type 2 diabetic kidney disease progression in American Indians","volume":"4","author":"Afshinnia","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.jlr.2026.100975_bib13","doi-asserted-by":"crossref","first-page":"7238","DOI":"10.1074\/jbc.RA117.000559","article-title":"Myeloperoxidase-derived oxidants damage artery wall proteins in an animal model of chronic kidney disease\u2013accelerated atherosclerosis","volume":"293","author":"Zeng","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jlr.2026.100975_bib14","doi-asserted-by":"crossref","first-page":"100120","DOI":"10.1074\/jbc.RA120.014095","article-title":"Deletion of bone marrow myeloperoxidase attenuates chronic kidney disease accelerated atherosclerosis","volume":"296","author":"Mathew","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jlr.2026.100975_bib15","first-page":"1","article-title":"Metabolomic profiling of arginine metabolome links altered methylation to chronic kidney disease accelerated atherosclerosis","volume":"s14","author":"Mathew","year":"2015","journal-title":"J. Proteomics Bioinform."},{"key":"10.1016\/j.jlr.2026.100975_bib16","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ekir.2016.08.007","article-title":"Lipidomic signature of progression of chronic kidney disease in the chronic renal insufficiency cohort","volume":"1","author":"Afshinnia","year":"2016","journal-title":"Kidney Int. Rep."},{"key":"10.1016\/j.jlr.2026.100975_bib17","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.86976","article-title":"Tissue-specific metabolic reprogramming drives nutrient flux in diabetic complications","volume":"1","author":"Sas","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.jlr.2026.100975_bib18","first-page":"002","article-title":"Targeted lipidomic and transcriptomic analysis identifies dysregulated renal ceramide metabolism in a mouse model of diabetic kidney disease","volume":"Suppl 14","author":"Sas","year":"2015","journal-title":"J. Proteomics Bioinform."},{"key":"10.1016\/j.jlr.2026.100975_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-021-23958-4","article-title":"Measurement of lipogenic flux by deuterium resolved mass spectrometry","volume":"12","author":"Fu","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jlr.2026.100975_bib20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11306-021-01816-0","article-title":"Renin-angiotensin system inhibition reverses the altered triacylglycerol metabolic network in diabetic kidney disease","volume":"17","author":"Sas","year":"2021","journal-title":"Metabolomics"},{"key":"10.1016\/j.jlr.2026.100975_bib21","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/bioinformatics\/btx012","article-title":"Sparse network modeling and metscape-based visualization methods for the analysis of large-scale metabolomics data","volume":"33","author":"Basu","year":"2017","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jlr.2026.100975_bib22","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1210\/me.2015-1301","article-title":"Loss of fatty acid binding protein 4\/aP2 reduces macrophage inflammation through activation of SIRT3","volume":"30","author":"Xu","year":"2016","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.jlr.2026.100975_bib23","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.cmet.2020.05.003","article-title":"Toll-like receptors induce signal-specific reprogramming of the macrophage lipidome","volume":"32","author":"Hsieh","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.jlr.2026.100975_bib24","first-page":"2993","article-title":"New insights on the role of lipid metabolism in the metabolic reprogramming of macrophages","volume":"1","author":"Prados-Rosales","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jlr.2026.100975_bib25","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.120.050686","article-title":"Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options","volume":"143","author":"Jankowski","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jlr.2026.100975_bib26","article-title":"Regulation of HDL dysfunctionality by phosphatidylethanolamine links poly-unsaturated fatty acids with atherosclerotic cardiovascular diseases","volume":"103","author":"Taradeh","year":"2025","journal-title":"Mol. Metab."},{"key":"10.1016\/j.jlr.2026.100975_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.104975","article-title":"NAD metabolism modulates inflammation and mitochondria function in diabetic kidney disease","volume":"299","author":"Myakala","year":"2023","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jlr.2026.100975_bib28","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.2337\/db15-0575","article-title":"RAGE suppresses ABCG1-mediated macrophage cholesterol efflux in diabetes","volume":"64","author":"Daffu","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.jlr.2026.100975_bib29","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.jacl.2025.09.002","article-title":"Joint association of plasma ceramide and renal function with coronary artery lesion severity: the CRUISE-MET study","volume":"19","author":"Chen","year":"2025","journal-title":"J. Clin. Lipidol."},{"key":"10.1016\/j.jlr.2026.100975_bib30","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.toxlet.2021.07.012","article-title":"Sphingolipid imbalance and inflammatory effects induced by uremic toxins in heart and kidney cells are reversed by dihydroceramide desaturase 1 inhibition","volume":"350","author":"Savira","year":"2021","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.jlr.2026.100975_bib31","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/978-3-030-60204-8_13","article-title":"Biological functions of plasmalogens","volume":"1299","author":"Hossain","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.jlr.2026.100975_bib32","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.bbalip.2003.12.010","article-title":"Functions and biosynthesis of plasmalogens in health and disease","volume":"1636","author":"Brites","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jlr.2026.100975_bib33","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1194\/jlr.M200340-JLR200","article-title":"Ethanolamine plasmalogens prevent the oxidation of cholesterol by reducing the oxidizability of cholesterol in phospholipid bilayers","volume":"44","author":"Maeba","year":"2003","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jlr.2026.100975_bib34","doi-asserted-by":"crossref","first-page":"419","DOI":"10.15761\/JTS.1000419","article-title":"Plasma lipidomic profiling identifies a novel complex lipid signature associated with ischemic stroke in chronic kidney disease","volume":"6","author":"Afshinnia","year":"2020","journal-title":"J. Transl. Sci."},{"key":"10.1016\/j.jlr.2026.100975_bib35","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/MOL.0b013e32833884bb","article-title":"Acyl-coenzyme A synthetases in metabolic control","volume":"21","author":"Ellis","year":"2010","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.jlr.2026.100975_bib36","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/JLB.3HI0219-045RR","article-title":"Acyl-CoA synthetase 1 exacerbates lipotoxic inflammasome activation in primary macrophages HHS public access","volume":"106","author":"Kalugotla","year":"2019","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jlr.2026.100975_bib37","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1111600109","article-title":"Diabetes promotes an inflammatory macrophage phenotype and atherosclerosis through acyl-CoA synthetase 1","volume":"109","author":"Kanter","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jlr.2026.100975_bib38","doi-asserted-by":"crossref","first-page":"100730","DOI":"10.1016\/j.jlr.2024.100730","article-title":"Type I IFN induces long-chain acyl-CoA synthetase 1 to generate a phosphatidic acid reservoir for lipotoxic saturated fatty acids","volume":"66","author":"Barnhart","year":"2025","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jlr.2026.100975_bib39","doi-asserted-by":"crossref","DOI":"10.4110\/in.2023.23.e28","article-title":"Comprehensive lipid profiling recapitulates enhanced lipolysis and fatty acid metabolism in intimal foamy macrophages from murine atherosclerotic aorta","volume":"23","author":"Seo","year":"2023","journal-title":"Immune Netw."}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227526000015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227526000015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T17:05:39Z","timestamp":1772298339000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022227526000015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0022227526000015"],"URL":"https:\/\/doi.org\/10.1016\/j.jlr.2026.100975","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic kidney disease induces distinct alterations of macrophage lipid metabolism in a mouse model of atherosclerosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Lipid Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jlr.2026.100975","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"100975"}}